{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:22:39Z","timestamp":1787620959216,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00435","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:52:07Z","timestamp":1588135927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Metformin as Host-Directed Therapy for TB Treatment: Scoping Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Nikita","family":"Naicker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/jac\/dkq007","article-title":"Comparison of the \u2018Denver regimen\u2019 against acute tuberculosis in the mouse and guinea pig.","volume":"65","author":"Ahmad","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/519841","article-title":"The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.","volume":"45","author":"Alisjahbana","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1124\/jpet.109.164970","article-title":"Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in Vitro.","volume":"334","author":"Arai","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework.","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.1099390","article-title":"Bacterial persistence as a phenotypic switch.","volume":"305","author":"Balaban","year":"2004","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3201\/eid1602.090968","article-title":"Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.","volume":"16","author":"Calver","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"B7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-76-3-112-6-407","article-title":"A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen.","volume":"112","author":"Cohn","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"B8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199508313330910","article-title":"Metformin.","volume":"333","author":"Crofford","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B9","article-title":"The effect of diabetes and comorbidities on tuberculosis treatment outcomes. A62. Treatment of tuberculosis.","volume":"195","author":"Degner","year":"2017","journal-title":"Am. Thorac. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/cid\/cix819","article-title":"Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment.","volume":"66","author":"Degner","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00652-17","article-title":"Metformin adjunctive therapy does not improve the sterilizing activity of the first-line antitubercular regimen in mice.","volume":"61","author":"Dutta","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies.","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1128\/jvi.00495-12","article-title":"Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase.","volume":"86","author":"Grady","year":"2012","journal-title":"J. Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/imr.12255","article-title":"New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.","volume":"264","author":"Hawn","year":"2015","journal-title":"Immunol. Rev."},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1038\/npjsba.2016.18","article-title":"The NAD World 2.0: the importance of the inter-tissue communication mediated by NAMPT\/NAD(+)\/SIRT1 in mammalian aging and longevity control.","volume":"2","author":"Imai","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/mdr.2006.12.231","article-title":"Comparison of the proteome of isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis.","volume":"12","author":"Jiang","year":"2006","journal-title":"Microb. Drug Resist."},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jprot.2013.08.025","article-title":"Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.","volume":"94","author":"Kumar","year":"2013","journal-title":"J. Proteomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/infdis\/jiz064","article-title":"Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects.","volume":"220","author":"Lachmandas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3904\/kjim.2017.249","article-title":"The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J. Intern. Med."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology.","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease.","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.celrep.2017.01.007","article-title":"The nuclear receptor LXR limits bacterial infection of host macrophages through a mechanism that impacts cellular NAD metabolism.","volume":"18","author":"Matalonga","year":"2017","journal-title":"Cell Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00018-015-2119-4","article-title":"Exploring NAD+ metabolism in host-pathogen interactions.","volume":"73","author":"Mesquita","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B25","first-page":"1","author":"Millington","year":"2018","journal-title":"Ending Tuberculosis, K4D Emerging Issues Report."},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijtb.2018.04.003","article-title":"Metformin induced autophagy in diabetes mellitus \u2013 tuberculosis co-infection patients: a case study.","volume":"66","author":"Novita","year":"2019","journal-title":"Indian J. Tuberc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijtb.2017.05.008","article-title":"A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.","volume":"65","author":"Novita","year":"2018","journal-title":"Indian J. Tuberc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tips.2015.05.005","article-title":"Exploring the potential of adjunct therapy in tuberculosis.","volume":"36","author":"Rayasam","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00465","article-title":"M. tuberculosis hypothetical proteins and proteins of unknown function: hope for exploring novel resistance mechanisms as well as future target of drug resistance.","volume":"8","author":"Sharma","year":"2017","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02452","article-title":"Repurposing and revival of the drugs: a new approach to combat the drug resistant tuberculosis.","volume":"8","author":"Sharma","year":"2017","journal-title":"Front. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139414","article-title":"Comparative proteomic analysis of aminoglycosides resistant and susceptible Mycobacterium tuberculosis clinical isolates for exploring potential drug targets.","volume":"10","author":"Sharma","year":"2015","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01816","article-title":"Cytosolic proteome profiling of aminoglycosides resistant Mycobacterium tuberculosis clinical isolates using MALDI-TOF\/MS.","volume":"7","author":"Sharma","year":"2016","journal-title":"Front. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/1477-5956-8-59","article-title":"Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis.","volume":"8","author":"Sharma","year":"2010","journal-title":"Proteome Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/qco.0b013e3283210020","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.","volume":"22","author":"Shenoi","year":"2009","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0b013e3283210020","article-title":"Methods to Inhibit Intracellular Growth of Bacteria and to Treat Bacteria-mediated Diseases, Google Patents. U.S. Patent No 9539222","author":"Singhal","year":"2017"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy.","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bjid.2017.01.001","article-title":"Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility.","volume":"21","author":"Srujitha","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2795090","article-title":"The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases.","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxidat. Med. Cell. Longev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijtb.2015.11.001","article-title":"WHO\u2019s end TB strategy: from stopping to ending the global TB epidemic.","author":"Uplekar","year":"2015","journal-title":"Indian J. Tuberc."},{"key":"B40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new End TB Strategy.","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-014-0263-5","article-title":"Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets.","volume":"12","author":"Vashisht","year":"2014","journal-title":"J. Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0443-y","article-title":"Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis.","volume":"13","author":"Vashisht","year":"2015","journal-title":"J. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1229858","article-title":"Dynamic persistence of antibiotic-stressed mycobacteria.","volume":"339","author":"Wakamoto","year":"2013","journal-title":"Science"},{"key":"B44","year":"2013","journal-title":"WHO Model List of Essential Medicines."},{"key":"B45","first-page":"1","year":"","journal-title":"Global Tuberculosis Report."},{"key":"B46","year":"","journal-title":"The End TB Strategy. 2015."},{"key":"B47","first-page":"1","year":"2018","journal-title":"Global Tuberculosis Report."},{"key":"B48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0005-2728(98)00023-1","article-title":"Procaryotic complex I (NDH-1), an overview.","volume":"1364","author":"Yagi","year":"1998","journal-title":"Biochim. Biophys. Acta Bioenergetics"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e14","article-title":"The role of reactive oxygen species in regulating T cell-mediated immunity and disease.","volume":"18","author":"Yarosz","year":"2018","journal-title":"Immune Netw."},{"key":"B50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens.","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:52:11Z","timestamp":1588135931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":50,"alternative-id":["10.3389\/fmicb.2020.00435"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00435","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"article-number":"435"}}